J C Boehm - JoVE Visualize

Showing results (11-20 of 22) with videos related to

Pageof 3

Sort By:

Journal of Medicinal Chemistry|September 1, 1977

Synthesis and biological activity of some broad-spectrum N-acylphenyglycine cephalosporinsR M DeMarinis, J C Boehm, J V Uri, et al.

Journal of Medicinal Chemistry|October 29, 1993

Synthesis and LTB4 receptor antagonist activities of the naturally occurring LTB4 receptor antagonist Leucettamine A and related analoguesJ C Boehm, J G Gleason, I Pendrak, et al.

Biochemistry|January 26, 1993

A symmetric inhibitor binds HIV-1 protease asymmetricallyG B Dreyer, J C Boehm, B Chenera, et al.

Journal of Medicinal Chemistry|January 1, 1977

Semisynthetic cephalosporins. Synthesis and structure-activity relationships of analogues with 7-acyl groups derived from 2-(cyanomethylthio)acetic acid or 2-[(2,2,2-trifluoroethyl)thio]acetic acid and their sulfoxides and sulfonesR M DeMarinis, J C Boehm, G L Dunn, et al.

Journal of Medicinal Chemistry|October 29, 1993

Synthesis of structural analogs of leukotriene B4 and their receptor binding activityW D Kingsbury, I Pendrak, J D Leber, et al.

Structure (London, England : 1993)|October 1, 1998

Structural basis of inhibitor selectivity in MAP kinasesZ Wang, B J Canagarajah, J C Boehm, et al.

Bioorganic & Medicinal Chemistry Letters|October 13, 2001

Pyrimidinylimidazole inhibitors of p38: cyclic N-1 imidazole substituents enhance p38 kinase inhibition and oral activityJ L Adams, J C Boehm, T F Gallagher, et al.

Bioorganic & Medicinal Chemistry Letters|January 5, 1999

Pyrimidinylimidazole inhibitors of CSBP/p38 kinase demonstrating decreased inhibition of hepatic cytochrome P450 enzymesJ L Adams, J C Boehm, S Kassis, et al.

Journal of Medicinal Chemistry|January 1, 1991

Synthesis of water-soluble (aminoalkyl)camptothecin analogues: inhibition of topoisomerase I and antitumor activityW D Kingsbury, J C Boehm, D R Jakas, et al.

Arthritis and Rheumatism|January 22, 2000

Disease-modifying activity of SB 242235, a selective inhibitor of p38 mitogen-activated protein kinase, in rat adjuvant-induced arthritisA M Badger, D E Griswold, R Kapadia, et al.

Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:

Pageof 3

Journal of Medicinal Chemistry|September 1, 1977

Synthesis and biological activity of some broad-spectrum N-acylphenyglycine cephalosporinsR M DeMarinis, J C Boehm, J V Uri, et al.

Journal of Medicinal Chemistry|October 29, 1993

Synthesis and LTB4 receptor antagonist activities of the naturally occurring LTB4 receptor antagonist Leucettamine A and related analoguesJ C Boehm, J G Gleason, I Pendrak, et al.

Biochemistry|January 26, 1993

A symmetric inhibitor binds HIV-1 protease asymmetricallyG B Dreyer, J C Boehm, B Chenera, et al.

Journal of Medicinal Chemistry|January 1, 1977

Semisynthetic cephalosporins. Synthesis and structure-activity relationships of analogues with 7-acyl groups derived from 2-(cyanomethylthio)acetic acid or 2-[(2,2,2-trifluoroethyl)thio]acetic acid and their sulfoxides and sulfonesR M DeMarinis, J C Boehm, G L Dunn, et al.

Journal of Medicinal Chemistry|October 29, 1993

Synthesis of structural analogs of leukotriene B4 and their receptor binding activityW D Kingsbury, I Pendrak, J D Leber, et al.

Structure (London, England : 1993)|October 1, 1998

Structural basis of inhibitor selectivity in MAP kinasesZ Wang, B J Canagarajah, J C Boehm, et al.

Bioorganic & Medicinal Chemistry Letters|October 13, 2001

Pyrimidinylimidazole inhibitors of p38: cyclic N-1 imidazole substituents enhance p38 kinase inhibition and oral activityJ L Adams, J C Boehm, T F Gallagher, et al.

Bioorganic & Medicinal Chemistry Letters|January 5, 1999

Pyrimidinylimidazole inhibitors of CSBP/p38 kinase demonstrating decreased inhibition of hepatic cytochrome P450 enzymesJ L Adams, J C Boehm, S Kassis, et al.

Journal of Medicinal Chemistry|January 1, 1991

Synthesis of water-soluble (aminoalkyl)camptothecin analogues: inhibition of topoisomerase I and antitumor activityW D Kingsbury, J C Boehm, D R Jakas, et al.

Arthritis and Rheumatism|January 22, 2000

Disease-modifying activity of SB 242235, a selective inhibitor of p38 mitogen-activated protein kinase, in rat adjuvant-induced arthritisA M Badger, D E Griswold, R Kapadia, et al.

Pageof 3